A detailed history of High Tower Advisors, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, High Tower Advisors, LLC holds 43,052 shares of ATAI stock, worth $49,079. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,052
Previous 44,189 2.57%
Holding current value
$49,079
Previous $87,000 34.48%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$1.27 - $2.6 $1,443 - $2,956
-1,137 Reduced 2.57%
43,052 $57,000
Q1 2024

May 06, 2024

SELL
$1.5 - $2.19 $1,125 - $1,642
-750 Reduced 1.67%
44,189 $87,000
Q4 2023

Feb 12, 2024

SELL
$1.04 - $1.55 $1,702 - $2,537
-1,637 Reduced 3.51%
44,939 $63,000
Q3 2023

Nov 08, 2023

SELL
$1.27 - $2.28 $18,288 - $32,832
-14,400 Reduced 23.62%
46,576 $60,000
Q2 2023

Aug 14, 2023

SELL
$1.44 - $2.19 $17,478 - $26,582
-12,138 Reduced 16.6%
60,976 $104,000
Q1 2023

May 11, 2023

BUY
$1.17 - $2.7 $34,749 - $80,190
29,700 Added 68.41%
73,114 $132,000
Q4 2022

Feb 08, 2023

BUY
$2.38 - $3.55 $7,140 - $10,650
3,000 Added 7.42%
43,414 $115,000
Q3 2022

Nov 09, 2022

BUY
$3.14 - $4.87 $126,899 - $196,816
40,414 New
40,414 $132,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $189M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.